elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38303998-222C1AC5-409D-4BA2-824E-B491372327E5
Q38303998-222C1AC5-409D-4BA2-824E-B491372327E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38303998-222C1AC5-409D-4BA2-824E-B491372327E5
Evolution from double to triple-antimalarial drug combinations.
P2860
Q38303998-222C1AC5-409D-4BA2-824E-B491372327E5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38303998-222C1AC5-409D-4BA2-824E-B491372327E5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
35cc183c861e7c037621442a920ca9852e4dd43f
P2860
Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.